{"schema_version":"secwatch.filing_event.v1","accession":"0001636422-26-000031","form_type":"8-K","ticker":"HCAT","cik":"0001636422","company_name":"Health Catalyst, Inc.","filed_at":"2026-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.707071+00:00","generated_at":"2026-05-15T13:32:48.607879+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Health Catalyst reports Q4 revenue down 6% YoY; net loss widens to $91M","bullets":["Full-year 2025 revenue $311.1M, up 1% YoY; Q4 revenue $74.7M, down 6% YoY.","Q4 net loss $91.0M vs $20.7M in Q4 2024; full-year net loss $178.0M vs $69.5M.","Adjusted EBITDA for full-year 2025 was $41.4M.","CEO Ben Albert cited opportunities and areas for improvement; focused on long-term success."],"urls":{"canonical":"https://secwatch.observer/filing/0001636422-26-000031","json":"https://secwatch.observer/filing/0001636422-26-000031.json","markdown":"https://secwatch.observer/filing/0001636422-26-000031.md","text":"https://secwatch.observer/filing/0001636422-26-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/0001636422-26-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/hcat-20260312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T13:32:48.607879+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"164e44b68cb0e4ce17a33817f47848816208874e","claim":"Health Catalyst, Inc. reported the quarter ended December 31, 2025 results: revenue $ 74,679, net income $ (91,025).","evidence_excerpt":"Months Ended December 31, Year over Year Change 2025 2024 2025 2024 GAAP Financial Measures: (in thousands, except percentages) (in thousands, except percentages) Total revenue $ 74,679 $ 79,606 (6)% $ 311,136 $ 306,584 1% Gross profit $ 31,385 $ 28,618 10% $ 120,356 $ 114,503 5% Gross margin 42.0 % 35.9 % 38.7 % 37.3 % Net loss $ (91,025) $ (20,673) (340)% $","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/0001636422-26-000031-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2025"},{"label":"Revenue","value":"$ 74,679"},{"label":"Net income","value":"$ (91,025)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c3bf41121a3642380fe862a12e74622ee4050c54","claim":"Health Catalyst, Inc. reported the year ended December 31, 2025 results: revenue $311.1 million, net income $ (177,974).","evidence_excerpt":"We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/0001636422-26-000031-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2025"},{"label":"Revenue","value":"$311.1 million"},{"label":"Net income","value":"$ (177,974)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}